It is worth mentioning that FBLN5 can block ROS production and oxidative damage elicited by fibronectin-β1 integrin signaling in pancreatic cancer via competing with fibronectin for β1 integrin binding [49, 50]. The gene discussed is FBLN5; the disease is pancreatic neoplasm.